Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paraneoplastic Ma antigen family-like 2 pseudogene (ENSG00000278797) is a non-coding locus with sequence similarity to functional PNMA2 and paralogs, but it lacks coding potential and does not produce a protein or function as a receptor or therapeutic target[2][8]. In the human genome, pseudogenes such as this are annotated as nonfunctional, although some pseudogenes can sometimes generate RNA transcripts that have regulatory functions; for this specific pseudogene, there is no evidence of functional activity[2][5]. The protein-coding family member PNMA2 is associated with paraneoplastic neurological syndromes and cancer-related autoimmune disorders, but the pseudogene does not participate in these processes[3][6][4].
None — no drugs or biologics have mechanisms of action involving this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paraneoplastic Ma antigen family-like 2 pseudogene (None).